Previous investigations showed that advanced stage bladder cancer (≥pT2) is associated with the mutation of tumor suppressor gene PTEN, which could play a negative regulatory role in the PI3K/Akt signaling pathway [10,11]. This evidence concerns the gene AKT1 and urinary bladder carcinoma.